Features | Partner Sites | Information | LinkXpress
Sign In
Schiller
Agfa Healthcare
Ampronix

Histotripsy System Developed to Treat Benign Prostatic Hyperplasia

By Medimaging International staff writers
Posted on 03 Jun 2014
Image: The Vortx Rx histotripsy machine (Photo courtesy of HistoSonics).
Image: The Vortx Rx histotripsy machine (Photo courtesy of HistoSonics).
New technology is providing the surgeon with tools to plan and deliver histotripsy, a non-thermal therapy for the treatment of benign prostate hyperplasia (BPH), a noncancerous enlargement of the prostate. The histotripsy treatment starts with three-dimensional (3D) ultrasound image reconstruction of the prostate. The urologist then generates a 3D outline of the target tissue volume to be treated.

After confirmation of the procedure plan, the urologist precisely navigates the histotripsy treatment through the target volume using joystick controls. The urologist monitors the procedure in real time with ultrasound image guidance throughout the treatment.

Histotripsy employs high intensity acoustic energy to fragment and homogenize cellular tissues through a process known as cavitation. Cavitation appears as a “bubble cloud” on ultrasound imaging and is easily monitored by the surgeon throughout the procedure. Because histotripsy is a mechanical, non-thermal process, the boundary between treated and untreated tissues is very precise. Once treated, tissues change in ultrasound appearance from bright to dark, enabling the surgeon to easily track the treatment as it progresses.

The Vort RX, developed by HistoSonics (Ann Arbor, MI, USA), is an investigational device and is limited by law to investigational use by qualified investigators in the United States and Canada. The company has raised more than USD 14 million in equity financing to support its ultrasound-powered ablation technology, a device the company reported can treat enlarged prostates without the need for surgery.

The device is designed to provide an alternative to pharmaceutical therapy and minimally invasive procedures such as urethra-based ablation, according to HistoSonics spokespersons, and the company believes its technology can enhance patient outcomes and lower healthcare costs.

The company, which spun out of the University of Michigan (Ann Arbor, MI, USA) in 2009, is in the process of undergoing pilot studies for Vortx Rx in the United States and Canada, treating its first US patient in August 2014.

Related Links:

HistoSonics 



Channels

Radiography

view channel
Image: Whole body images of a mouse before and after nanoparticles injections. Signal loss in the liver and the spleen due to the accumulation of iron from the nanoparticles is indicated by the red arrows. (Photo courtesy of Imperial College London).

Self-Assembling Nanoparticles Could Improve Cancer Diagnosis

Innovative nanoparticles boost the effectiveness of magnetic resonance imaging (MRI) scanning by specifically seeking out receptors that are found in cancerous cells. Developed by researchers at Imperial... Read more

MRI

view channel
Image: Probability map of the brain regions activated in functional magnetic resonance imaging (fMRI) by a silent sentence production task in a group of 144 right-handed individuals. The color scale indicates the percentage of subjects with significant activation in this area during the task (green: 50%, blue: 65%, red: 80% or more). Note the high asymmetry of the map in favor of the left hemisphere) [Gauche = Left, Droite = Right] (Photo courtresy of Groupe d\'Imagerie Neurofonctionnelle, CNRS/CEA/Université de Bordeaux, France).

fMRI and Database Show a Dominant Side of the Brain for Handedness and Language

Utilizing a large psychometric and brain imaging database, researchers have demonstrated that the location of language areas in the brain is independent of left- or right-handedness, except for a very... Read more

Nuclear medicine

view channel

Proton Therapy Has Better Outcome over IMRT for Advanced Head and Neck Cancers

Radiation oncologists compared the world’s literature on outcomes of proton beam therapy in the treatment of a range of advanced head and neck cancers of the skull base compared to intensity-modulated radiation therapy (IMRT) and found that proton beam therapy significantly improved disease-free survival and tumor control... Read more

General/Advanced Imaging

view channel
Image: Participant fitted with fNIRS headgear (Photo courtesy of University of Pittsburgh Schools of the Health Sciences).

Portable Optical Imaging Tool Designed for Concussion Evaluation

Researchers have demonstrated that a portable, low-cost optical imaging application is useful in evaluation of concussions. Two separate research projects, published recently, represent important steps... Read more

Imaging IT

view channel

Enterprise Imaging and Content Management Technology Collaboration Designed to Optimize the Electronic Health Record

A joint solution developed for the US market provides multi-media, electronic content management for electronic health records (EHRs). The system provides real-time access to a patient’s full medical history across the hospital enterprise, enhancing decision-making and healthcare while lowering costs. The integration... Read more

Industry News

view channel

Hosting and Distribution Collaboration Established to Provide Radiation Dose Monitoring

PHS Technologies Group, LLC (Scottsdale, AZ, USA), a unit of PACSHealth, LLC, and a developer of software that monitors patient exposure to ionizing radiation, reported that Dell Healthcare and Life Sciences (Round Rock, TX, USA) will become a marketing, distribution, and hosting partner for its DoseMonitor OnLine software.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.